Dr. David J Andorsky
Claim this profileRocky Mountain Cancer Centers USOR
Area of expertise
Follicular Lymphoma
David J Andorsky has run 2 trials for Follicular Lymphoma. Some of their research focus areas include:
Chronic Illness
David J Andorsky has run 2 trials for Chronic Illness. Some of their research focus areas include:
Affiliated Hospitals
Rocky Mountain Cancer Centers USOR
Rocky Mountain Cancer Centers (RMCC) - Boulder
Clinical Trials David J Andorsky is currently running
Revitalize Program
for Ovarian Cancer
The purpose of this study is to see whether a supportive intervention (REVITALIZE) reduces fatigue and its impact on daily life and activities for participants with ovarian cancer taking PARP inhibitors. The name of the study groups in this research study are: 1. REVITALIZE 2. Educational Materials
Recruiting
1 award
N/A
4 criteria
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting
1 award
Phase 3
4 criteria
More about David J Andorsky
Clinical Trial Related
4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments David J Andorsky has experience with
- Asciminib
- Tazemetostat
- Rituximab
- Nilotinib
- Lenalidomide
- ABL001
Breakdown of trials David J Andorsky has run
Follicular Lymphoma
Chronic Myelogenous Leukemia
Phenylketonuria
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David J Andorsky specialize in?
David J Andorsky focuses on Follicular Lymphoma and Chronic Illness. In particular, much of their work with Follicular Lymphoma has involved EZH2 positive patients, or patients who are CNG positive.
Is David J Andorsky currently recruiting for clinical trials?
Yes, David J Andorsky is currently recruiting for 2 clinical trials in Boulder Colorado. If you're interested in participating, you should apply.
Are there any treatments that David J Andorsky has studied deeply?
Yes, David J Andorsky has studied treatments such as Asciminib, Tazemetostat, Rituximab.
What is the best way to schedule an appointment with David J Andorsky?
Apply for one of the trials that David J Andorsky is conducting.
What is the office address of David J Andorsky?
The office of David J Andorsky is located at: Rocky Mountain Cancer Centers USOR, Boulder, Colorado 80304 United States. This is the address for their practice at the Rocky Mountain Cancer Centers USOR.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.